| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |